Assessment of Knowledge, Practices, and Needs Regarding Positron Emission Tomography (PET) in Senegal ()
1. Introduction
Positron Emission Tomography (PET) is an advanced medical imaging technique that has become essential for the diagnosis and follow-up of numerous pathologies, particularly cancers, as well as certain neurological and cardiovascular disorders. It relies on the administration of radiotracers, which are biologically active molecules labeled with positron-emitting radioisotopes such as fluorine-18 or carbon-11. These radiotracers allow the generation of high-resolution functional images that provide information complementary to conventional morphological imaging [1].
Because of their short half-lives [2], radiotracers must be produced close to imaging centers. This requires specialized infrastructure, including cyclotrons and radiopharmacy laboratories.
In many African countries, the development of PET is limited by financial, logistical, and regulatory constraints [3] [4]. In Senegal, the current absence of a PET center and a radiotracer production unit represents a major barrier to access to this technology, despite increasing diagnostic needs, particularly in oncology.
To document these needs and provide a basis for establishing a PET center and a radiotracer production facility, we conducted a survey among Senegalese healthcare professionals. The objective of this study was to assess their knowledge, practices, and needs related to PET imaging, in order to identify clinical and organizational priorities for its introduction.
2. Methodology
This was a descriptive cross-sectional study conducted from August 19 to September 30, 2025, involving healthcare professionals working in public and private healthcare facilities in Senegal.
The survey was conducted on a voluntary basis using an online questionnaire distributed electronically through professional emails, scientific groups, and medical committees of healthcare institutions. Participants were recruited using a convenience sampling approach, complemented by snowball sampling.
The parameters analyzed included:
Sociodemographic and professional characteristics
Knowledge related to Positron Emission Tomography
Current practices (prescriptions, known indications, barriers)
Needs and expectations regarding the development of a PET center in Senegal
These parameters were used to design a structured survey consisting of 26 questions (closed, semi-open, and open-ended) organized into five sections: general information about the respondent, knowledge of PET, PET scan requests, radiotracer supply, and human resources and competencies. The questionnaire was administered online via Microsoft Forms.
Collected data were exported to a spreadsheet and analyzed using a descriptive approach. Quantitative variables were expressed as means and ranges, while qualitative variables were presented as counts and percentages. Textual data from open-ended questions were analyzed using content analysis with Microsoft Excel.
3. Results
3.1. Sociodemographic Characteristics of the Surveyed Healthcare Professionals
A total of 120 healthcare professionals practicing in Senegal participated in the study. The main sociodemographic characteristics are presented in Table 1. The study population was predominantly male, with 74% men and 26% women, corresponding to a sex ratio of 2.9. The mean age of participants was 35.9 years. The most represented age group was over 30 years (68%), while 32% of respondents were 30 years old or younger.
Geographically, the majority of participants were based in the Dakar region (66.7%), the main hospital-university and medical-technical hub of the country. Thiès (11.7%) and Ziguinchor (5%) were the second and third most represented regions, respectively. Lower participation was noted in Diourbel (5.8%), Saint-Louis (4.2%), Kaolack (3.3%), Kaffrine (0.8%), Fatick (0.8%), Matam (0.8%), and Kolda (0.8%). No responses were received from the regions of Kédougou, Louga, and Sédhiou.
Regarding professional status, 49.2% of respondents were medical doctors, 18.3% pharmacists, and 2.5% medical physicists. The remaining participants belonged to various healthcare professional categories, including biologists, radiologists, specialized nurses, and senior technicians.
The sample displayed a notable diversity of medical (65.8%) and pharmaceutical (30.8%) specialties (Table 2). The most represented specialties were hospital pharmacy (15%), radiology (11.7%), surgery (10.8%), medical biology (10.8%), oncology (6.7%), nuclear medicine (4.2%), and cardiology (4.2%). Radiopharmacists accounted for 4.2% of respondents, while other specialties (anesthesiology and intensive care, internal medicine, pediatrics, etc.) were present in smaller proportions.
3.2. Knowledge of Senegalese Healthcare Professionals on PET Imaging
The assessment of general knowledge about positron emission tomography (PET)
Table 1. Sociodemographic characteristics of surveyed healthcare professionals (N = 120).
Characteristic |
Frequency |
Percentage |
Sex |
Male |
89 |
74% |
Female |
31 |
26% |
Age group |
≤30 years |
38 |
32% |
>30 years |
82 |
68% |
Professional status/Grade |
PhD in Biology |
1 |
0.8% |
Medical Doctor |
59 |
49.2% |
Doctor of Pharmacy |
22 |
18.3% |
Resident (DES student) |
9 |
7.5% |
Medical Student |
2 |
1.7% |
Nurse |
3 |
2.5% |
Medical Physicist |
3 |
2.5% |
Professor of Medicine |
9 |
7.5% |
Professor of Pharmacy |
5 |
4.2% |
Senior Technician in Applied Biology |
7 |
5.8% |
Region/Location |
Dakar |
80 |
66.7% |
Diourbel |
7 |
5.8% |
Fatick |
1 |
0.8% |
Kaffrine |
1 |
0.8% |
Kaolack |
4 |
3.3% |
Kédougou |
0 |
0% |
Kolda |
1 |
0.8% |
Louga |
0 |
0% |
Matam |
1 |
0.8% |
Saint-Louis |
5 |
4.2% |
Sédhiou |
0 |
0% |
Tambacounda |
0 |
0% |
Thiès |
14 |
11.7% |
Ziguinchor |
6 |
5% |
Table 2. Responses by specialty.
Training |
Specialty Medical |
Frequency |
Percentage |
Medicine |
Cardiology |
5 |
4.2% |
|
Nuclear Medicine |
5 |
4.2% |
|
Oncology |
8 |
6.7% |
|
Radiology |
14 |
11.7% |
|
Neurologie |
4 |
3.3% |
|
Other |
22 |
18.3% |
|
Surgical |
|
|
|
Urology |
4 |
3.3% |
|
Surgery |
13 |
10.8% |
|
Obstetrics and Gynecology |
4 |
3.3% |
Pharmacy |
Medical Biology |
13 |
10.8% |
|
Hospital Pharmacy |
18 |
15% |
|
Radiopharmacy |
5 |
4.2% |
|
Immunology |
1 |
0.8% |
Nursing |
Nursing care |
2 |
1.7% |
Physics |
Medical Physics |
2 |
1.7% |
revealed that 39.2% of participants achieved a perfect score (100% correct answers), whereas 60.8% demonstrated insufficient knowledge or were unable to define PET (Table 3).
Table 3. Level of knowledge and training of healthcare professionals on PET.
Variables |
Frequency |
Percentage |
Knowledge score on PET (out of 4) |
0 |
3 |
2.5% |
1 |
13 |
10.8% |
2 |
26 |
21.7% |
3 |
31 |
25.8% |
4 |
47 |
39.2% |
Self-assessed level of knowledge on PET |
None |
13 |
10.8% |
Poor |
47 |
39.2% |
Average |
36 |
30.0% |
Good |
19 |
15.8% |
Very good |
5 |
4.2% |
Participation in PET-related training or information sessions |
No |
63 |
52.5% |
No, but interested |
33 |
27.5% |
Yes |
24 |
20.0% |
Regarding self-assessment of PET knowledge, 4.2% of respondents reported having a very good level, 15.8% a good level, 30% an average level, 39.2% a poor level, and 10.8% declared having no knowledge at all in this field.
In addition, only 20% of healthcare professionals had previously received training or attended an information session on PET.
3.3. Uses of PET
Among the 120 healthcare professionals surveyed, only 11.7% reported prescribing positron emission tomography (PET) examinations, whereas 88.3% did not prescribe them at the time of the survey (Table 4).
Table 4. Prescription of PET examinations by healthcare professionals: distribution, frequency, and target pathologies.
Variables |
Frequency |
Percentage |
Distribution of healthcare professionals prescribing PET examinations |
No |
106 |
88.3% |
Yes |
14 |
11.7% |
Frequency of prescriptions |
0 |
2 |
1.7% |
Less than 5 |
15 |
12.5% |
5 - 10 |
1 |
0.8% |
11 - 20 |
1 |
0.8% |
More than 20 |
1 |
0.8% |
Not applicable |
100 |
83.3% |
Identification of relevant target pathologies for PET |
Digestive cancers |
65 |
54.2% |
Pulmonary cancers |
59 |
49.2% |
Urological cancers |
57 |
47.5% |
Lymphomas/Other malignant hematologic diseases |
47 |
39.2% |
Gynecological cancers |
49 |
40.8% |
Neurological pathologies |
29 |
24.2% |
Cardiac pathologies |
33 |
27.5% |
Other |
26 |
21.6% |
Regarding prescription frequency, 12.5% (N = 120) reported prescribing fewer than five PET scans per month, while 2.4% indicated prescribing between five and more than twenty per month, reflecting the still limited use of PET in clinical practice.
In terms of clinical indications, PET was mainly associated with oncological pathologies, particularly digestive cancers (54.2%), pulmonary cancers (49.2%), urological cancers (47.5%), gynecological cancers (40.8%), and lymphomas or other malignant hematologic diseases (39.2%). Cardiac (27.5%) and neurological (24.2%) indications were less frequently reported.
The main barriers to the use of PET (Table 5) were the absence of national availability of the examination (62.5%), followed by the lack of nearby PET centers (37.5%) and the high cost of the examinations (35.8%). In addition, 7.5% of respondents reported a lack of information regarding access to or procedures for PET use.
Table 5. Identification of barriers encountered by healthcare professionals regarding PET.
Responses |
Frequency |
Percentage |
High cost |
43 |
35.8% |
No nearby PET center |
45 |
37.5% |
Not available nationwide |
75 |
62.5% |
I don’t know/Uncertain |
9 |
7.5% |
3.4. Needs and Expectations
The needs and expectations of healthcare professionals regarding positron emission tomography (PET) in Senegal were explored across several dimensions, including the perceived future development of the technology, knowledge of radiotracers, strategic priorities, and required human resources.
Regarding the future development of PET in the country, 72.5% of respondents anticipated an increase in its use over the next five years, with 38.3% expecting a substantial rise. In contrast, 2.5% predicted no growth, and 25% did not express an opinion (Table 6).
Concerning radiotracers, 82.5% of professionals acknowledged that PET requires the use of specific radioactive molecules, whereas 12.5% indicated a lack of knowledge on this topic and 4.2% believed radiotracers were not essential. Furthermore, 77.5% were aware that their production requires specialized equipment (Table 7), although nearly half were unaware of the absence of a national production center in Senegal.
The most well-known radiotracers were [¹⁸F]-fluorodeoxyglucose (FDG), cited by 45.8% of respondents, followed by [¹⁸F]-fluoro-L-DOPA (17.5%), PSMA (16.7%), and DOTA-peptides (12.5%). Nevertheless, 45.8% reported being unfamiliar with radiotracers used in PET (Table 8).
A large majority of participants (85.8%) supported the establishment of a
Table 6. Estimated use of PET in the next five years.
Do you think PET use will increase in the next five years? |
Frequency |
Percentage |
I don’t know |
30 |
25% |
No |
3 |
2.5% |
Yes, substantially |
46 |
38.3% |
Yes, slightly |
41 |
34.2% |
Table 7. Use and production of radiotracers in PET, status of production in Senegal.
Statements |
Frequency |
Percentage |
A PET examination necessarily requires the use of radiotracers |
I don’t know |
15 |
12.5% |
No |
5 |
4.2% |
Yes |
99 |
82.5% |
Depends on the period |
1 |
0.8% |
Production of radiotracers requires specialized equipment |
I don’t know |
22 |
18.3% |
No |
5 |
4.2% |
Yes |
93 |
77.5% |
Are there radiotracer production centers in Senegal? |
I don’t know |
50 |
41.7% |
No |
61 |
50.8% |
Yes |
9 |
7.5% |
Table 8. Use of radiotracers in PET.
Which radiotracers do you use or would like to use? |
Frequency |
Percentage |
FDG (Fluorodeoxyglucose) |
55 |
45.8% |
NaF (Sodium Fluoride - 18F) |
14 |
11.7% |
DOPA (6-[18F] fluoro-L-DOPA) |
21 |
17.5% |
PSMA (Prostate-Specific Membrane Antigen) |
20 |
16.7% |
DOTATATE (DOTA-peptides) |
15 |
12.5% |
FLT (Fluorothymidine) |
3 |
2.5% |
I don’t know |
55 |
45.8% |
national radiotracer production facility to promote the development of PET in Senegal (Table 9). The priority locations proposed for its implementation were Dakar (89.2%), Ziguinchor (55%), Saint-Louis (53.3%), Diourbel (42.5%), and Thiès (35.8%).
Table 9. Healthcare professionals’ opinions on the establishment of a national radiotracer production facility, priority areas, and required professional profiles
Question/Item |
Frequency |
Percentage |
Do you think a national radiotracer production facility would be useful? |
Yes |
103 |
85.8% |
No opinion |
17 |
14.2% |
Which regions of the country should be prioritized for such an initiative? |
Dakar |
107 |
89.2% |
Diourbel |
51 |
42.5% |
Fatick |
15 |
12.5% |
Kaffrine |
11 |
9.2% |
Kaolack |
34 |
28.3% |
Kédougou |
21 |
17.5% |
Kolda |
16 |
13.2% |
Louga |
9 |
7.5% |
Matam |
18 |
15% |
Saint-Louis |
64 |
53.3% |
Sédhiou |
11 |
9.2% |
Tambacounda |
31 |
25.8% |
Thiès |
43 |
35.8% |
Ziguinchor |
66 |
55% |
I don’t know |
4 |
3.3% |
Which professional profiles are required for a radiotracer production facility? |
Biomedical engineer |
84 |
70% |
Nuclear medicine physician |
100 |
83.3% |
Medical physicist |
74 |
61.7% |
Radiopharmacy technician |
75 |
62.5% |
Radiopharmacist |
93 |
77.5% |
Specialist physicians |
48 |
40% |
I don’t know |
2 |
1.7% |
Finally, the professional profiles considered essential for the operation of such a facility included nuclear medicine physicians (83.3%), radiopharmacists (77.5%), biomedical engineers (70%), radiopharmacy technicians (62.5%), and medical physicists (61.7%).
4. Discussion
4.1. Respondent Distribution and Gender Aspects
This study involved 120 healthcare professionals practicing in Senegal, a country where positron emission tomography (PET) is not yet available. The surveyed population was predominantly male (74%, Table 1), with a sex ratio of 2.9, reflecting the distribution observed in national medical practice. The underrepresentation of women may be attributed to several factors: limited exposure to PET, lack of familiarity with the discipline, perceived constraints related to radiation protection, particularly for women of childbearing age, as well as sociocultural and structural factors limiting female participation in technological or radiation associated specialties. A study on interventional radiology in Subsaharan Africa demonstrated that these barriers, including the lack of female role models and family related constraints, reduce women’s participation in such fields [5]. To address this disparity, the future development of PET in Senegal should incorporate concrete measures aimed at promoting female participation. These could include targeted training programs in nuclear medicine, mentorship initiatives pairing junior female professionals with experienced practitioners, awareness campaigns highlighting career opportunities for women, and the implementation of gender sensitive radiation safety protocols. Such strategies would help ensure an inclusive, sustainable, and equitable growth of PET services in the country.
4.2. Knowledge Level and Perception of PET
Despite the absence of dedicated positron emission tomography (PET) facilities in Senegal, a majority of participants (82.5%, Table 7) reported a satisfactory understanding of the basic principles underlying this imaging modality. However, objective assessment of PET knowledge revealed that only 39.2% of respondents achieved a perfect score, while 60.8% demonstrated insufficient knowledge or were unable to define PET (Table 3). This discrepancy suggests that, although healthcare professionals are generally familiar with the concept and potential applications of PET, likely due to postgraduate training, international collaborations, and advanced programs abroad [6], their detailed or technical knowledge remains limited. These findings underscore the need for structured, formal training programs to strengthen both theoretical understanding and practical competency in molecular imaging among healthcare professionals in Senegal.
[¹⁸F]-fluorodeoxyglucose (FDG) remained the most recognized and frequently cited radiotracer by participants (Table 8). This predominance confirms its central role in PET, particularly in oncological applications where it remains the reference radiotracer for tumor detection, staging, and therapeutic follow-up [7] [8]. Other radiotracers, such as [¹⁸F]-DOPA, PSMA, and DOTA-peptides, were also mentioned, reflecting an emerging interest in precision nuclear medicine and functional characterization of tumor tissues [9] [10].
However, nearly half of the participants reported being unfamiliar with the different radiotracers, highlighting gaps in both initial and continuing education. These findings emphasize the need to strengthen continuing education and academic programs in nuclear medicine, radiopharmacy, medical physics, and biomedical engineering. To address these gaps, several studies recommend reinforcing local expertise to prepare for the effective introduction of PET into the African healthcare system [11]-[13].
4.3. Potential Uses and Areas of Interest
The current use of PET is non-existent in Senegal ; however, 11.7% of respondents reported having prescribed PET examinations. These prescriptions generally correspond to referrals to centers located outside the country, mainly in Morocco or France. Despite the absence of local PET facilities, the potential clinical applications of PET are clearly recognized by healthcare professionals. A large majority (72.5%, Table 6) anticipate a significant increase in PET utilization if the technology were to become available, particularly in the field of oncology (Table 4). The main barriers identified include the lack of infrastructure (62.5%, Table 5) and the relatively high cost of examinations (35.8%), reflecting both a strong latent demand and a high level of awareness of the clinical benefits of this diagnostic tool.
This perception aligns with observations from several international studies, which confirm that [¹⁸F]-fluorodeoxyglucose PET (FDG-PET) is the reference examination for assessing the initial extent of non-metastatic bronchopulmonary cancer [14]. Moreover, FDG-PET allows the detection of metastatic sites not identified by conventional imaging methods [15]. Its utility also extends to grading the malignancy of brain tumors and prognostic evaluation, thereby improving therapeutic planning and follow-up [16].
These results suggest a considerable potential for integrating PET into patient care in Senegal, particularly for digestive, pulmonary, urological, and gynecological cancers, where the added value of metabolic imaging is well documented.
4.4. Expressed Needs and Development Perspectives
Surveyed healthcare professionals expressed a clear and structured need for the development of PET and local production of radiotracers. The establishment of a national radiotracer production facility was deemed relevant by 85.8% of respondents (Table 9). Such an infrastructure would enable the provision of radiotracers close to nuclear medicine services, considering their short half-life, while ensuring a reliable and continuous supply, thereby reducing dependency on imports [17].
The prioritized implantation areas, Dakar, Ziguinchor, Saint-Louis, Thiès, and Diourbel, reflect a desire for a more equitable territorial distribution of molecular imaging. This choice mirrors the reality of a strong centralization of human resources and medical infrastructure in major cities, particularly Dakar, where approximately 70% of physicians and 80% of pharmacists and dentists are concentrated, although this region accounts for only about 42% of the national population [18] [19]. This unequal distribution limits access to specialized examinations and generates diagnostic delays, as reported in several studies conducted in sub-Saharan Africa [20]-[22].
These observations highlight the need for a structured national plan for the development of nuclear medicine in Senegal, including:
training of qualified human resources, particularly in nuclear medicine, radiopharmacy, medical physics, and biomedical engineering, to sustainably strengthen local expertise [20].
establishment of regional radiopharmacy units to ensure radiotracer availability, reduce logistical delays, and enhance system resilience.
promotion of sustainable scientific and technological autonomy by supporting applied research, knowledge transfer, and locally adapted production to meet clinical needs [17] [22].
Thus, the development of a national radiotracer production facility addresses not only a logistical challenge but also represents a strategic lever for territorial equity, improved diagnostic performance, and consolidation of local scientific competencies.
4.5. Study Limitations and Perspectives
This study has several limitations. First, the sample is predominantly concentrated in Dakar (Table 1), which limits national representativeness and the generalizability of the results to the entire country. Previous studies on the distribution of healthcare professionals in Senegal have shown that the capital disproportionately concentrates medical and paramedical staff, reflecting the same trends observed in our survey [18] [19]. Additionally, participants were recruited using a convenience sampling strategy with elements of snowball sampling, which may have introduced a selection bias and affected the diversity of respondents. This should be considered when interpreting the results, as it may limit the generalizability of findings to the wider population of healthcare professionals.
Second, the data collected were based on participants’ self-reported responses, which may be influenced by individual perceptions or subjective understanding of the questions, introducing potential perception bias. Such bias can arise from subjective interpretation of questions, partial recall, or social desirability [23]. Additionally, the quality of responses may vary depending on the mode of questionnaire administration, affecting comprehension, accuracy, and honesty of the answers provided [24]. Finally, using the same source to assess multiple variables can introduce common method bias, potentially inflating correlations and compromising causal interpretation [25].
Moreover, the current absence of PET in Senegal does not allow for the assessment of actual clinical use, but only of intentions, perceptions, and expectations of healthcare professionals.
Despite these limitations, the results highlight a clear interest in PET and well-identified needs. The development of a national radiotracer production facility, targeted training of qualified professionals, and establishment of regional PET centers represent strategic priorities for the effective and sustainable introduction of this technology, particularly in oncology [11]-[13].
Furthermore, female participation should be encouraged through specific training in radiobiology and radiation protection to ensure inclusive and sustainable integration into this high-potential sector, thereby promoting health equity and the development of local expertise [20] [21].
5. Conclusion
This study provides the first nationwide assessment of healthcare professionals’ perceptions, knowledge and expectations regarding positron emission tomography (PET) in Senegal. Beyond documenting current knowledge levels, it highlights a substantial latent demand for PET imaging, particularly in oncology, despite the absence of local facilities. These findings underscore the existence of a clear clinical need rather than a lack of awareness or interest among professionals. From a policy perspective, the results emphasize the strategic importance of investing in PET infrastructure, including the establishment of a national radiotracer production facility and the development of specialized training programs. Addressing structural barriers and promoting gender equity in nuclear medicine are essential steps to ensure sustainable and inclusive implementation. As a foundational study, this work provides valuable evidence to inform health policy decisions and investment planning in Senegal. More broadly, it serves as a reference framework for the development of nuclear medicine in West Africa, supporting improved diagnostic capacity, optimized therapeutic monitoring, and strengthened regional biomedical research.